“This case is very concerning for a number of reasons,” says Rick Bright, an American immunologist and vaccine researcher and a U.S. government health official from 2016 to 2020. “It’s in an otherwise healthy teenager. Like a similar case in Missouri, there’s no clear source for infection and no direct farm connection.”
New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.
While long COVID is not usually immediately or directly life-threatening, it’s possible it could exacerbate existing conditions, and play a role in a person’s death in this way.
Recent Comments